| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $23.29M | - | |
| Other | 138.6K | $7.46M | - | |
| Other | 123.1K | $6.62M | - | |
| CFO | 116.9K | $6.29M | - | |
| Other | 111.5K | $6.00M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2019 | Clague Laura64 | Chief Financial Officer | Sell | 2,033 | $21.44 | $43,587.46 | -8.8% | |
| Feb 12, 2019 | Aselage Steve80 | Chief Executive Officer | Sell | 2,130 | $21.44 | $45,667.20 | -0.4% | |
| Jan 9, 2019 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 1,500 | $23.96 | $35,932.50 | -4.3% | |
| Dec 21, 2018 | Clague Laura64 | Chief Financial Officer | Sell | 7,500 | $21.96 | $164,664.71 | -15.5% | |
| Dec 21, 2018 | Aselage Steve80 | Chief Executive Officer | Sell | 12,376 | $21.88 | $270,787.85 | -1.5% | |
| Dec 20, 2018 | McFarlane Neil F. | Chief Operating Officer | Sell | 11,125 | $22.32 | $248,333.18 | -14.7% | |
| Dec 7, 2018 | Aselage Steve80 | Chief Executive Officer | Sell | 10 | $24.04 | $240.37 | - | |
| Nov 15, 2018 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 5,000 | $24.03 | $120,145.93 | -5.0% | |
| Nov 15, 2018 | Clague Laura64 | Chief Financial Officer | Sell | 7,500 | $24.02 | $180,137.51 | -11.7% | |
| Nov 15, 2018 | Rote William E.58 | Senior Vice President, R&D | Sell | 5,000 | $24.03 | $120,129.55 | -6.1% |